Healthcare -
Biotechnology - NASDAQ - US
$ 243.34
-1.38 %
$ 31.5 B
Market Cap
-112.14
P/E
ALNY - TOTAL CURRENT ASSETS
Total Current Assets ALNY - Alnylam Pharmaceuticals, Inc.
3.3 B
LAST VALUE
10.63%
2 YEAR CAGR
13.70%
5 YEAR CAGR
12.37%
10 YEAR CAGR